GLI
ALXN

Guardian Life Insurance’s Alexion Pharmaceuticals ALXN Stock Holding History

Guardian Life Insurance’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-653
Closed -$71K – 500
2019
Q4 		$71K Hold
653
– – 0.02% 251
2019
Q3 		$64K Buy
653
+9
+1% +$1.01K 0.01% 273
2019
Q2 		$84K Hold
644
– – 0.01% 215
2019
Q1 		$87K Buy
644
+16
+3% +$1.99K 0.01% 205
2018
Q4 		$61K Hold
628
– – 0.01% 240
2018
Q3 		$87K Buy
628
+16
+3% +$2.01K 0.01% 202
2018
Q2 		$76K Buy
612
+98
+19% +$11.5K 0.01% 209
2018
Q1 		$57K Sell
514
-208
-29% -$24.9K 0.01% 226
2017
Q4 		$86K Buy
722
+218
+43% +$26.5K 0.02% 220
2017
Q3 		$71K Hold
504
– – 0.01% 189
2017
Q2 		$61K Sell
504
-361
-42% -$42K 0.01% 201
2017
Q1 		$105K Buy
865
+6
+0.7% +$774 0.02% 201
2016
Q4 		$105K Buy
859
+20
+2% +$2.45K 0.02% 205
2016
Q3 		$103K Hold
839
– – 0.01% 227
2016
Q2 		$98K Buy
839
+5
+0.6% +$709 0.01% 251
2016
Q1 		$116K Sell
834
-235
-22% -$34.5K 0.01% 220
2015
Q4 		$204K Sell
1,069
-246
-19% -$43K 0.02% 171
2015
Q3 		$206K Buy
1,315
+334
+34% +$60.9K 0.02% 190
2015
Q2 		$177K Buy
981
+97
+11% +$16.7K 0.02% 185
2015
Q1 		$153K Sell
884
-241
-21% -$43.6K 0.01% 207
2014
Q4 		$208K Hold
1,125
– – 0.02% 198
2014
Q3 		$187K Buy
1,125
+21
+2% +$3.45K 0.02% 205
2014
Q2 		$173K Hold
1,104
– – 0.02% 215
2014
Q1 		$168K Hold
1,104
– – 0.01% 222
2013
Q4 		$147K Sell
1,104
-1,245
-53% -$149K 0.01% 236
2013
Q3 		$273K Hold
2,349
– – 0.02% 245
2013
Q2 		$217K Buy
+2,349
New +$226K 0.02% 276

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Guardian Life Insurance's ALXN Position: Q1 2020 in Review

Guardian Life Insurance sold out of Alexion Pharmaceuticals (ALXN) in Q1 2020, closing a stake of 653 shares — an estimated $71K sold.

Guardian Life Insurance first reported a position in ALXN in Q2 2013 and held it in 27 quarters. The position peaked at $273K in Q3 2013. 653 funds tracked by Wall St. Rank hold ALXN as of Q1 2020.

  • Guardian Life Insurance reported no remaining Alexion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Guardian Life Insurance sold 653 Alexion Pharmaceuticals shares in Q1 2020, an estimated $71K.
  • Guardian Life Insurance first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 27 quarters.
  • Guardian Life Insurance's Alexion Pharmaceuticals position peaked at $273K in Q3 2013.
  • 653 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2020.

Based on Guardian Life Insurance's 13F filing for Q1 2020.